Form 8-K - Current report:
SEC Accession No. 0001185185-25-000398
Filing Date
2025-05-05
Accepted
2025-05-05 16:23:06
Documents
16
Period of Report
2025-04-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tcrg8k050525.htm   iXBRL 8-K 42013
2 EXHIBIT 99.1 tcrgex99-1.htm EX-99.1 13068
3 EXHIBIT 99.2 tcrgex99-2.htm EX-99.2 8074
4 EXHIBIT 99.3 tcrgex99-3.htm EX-99.3 11753
  Complete submission text file 0001185185-25-000398.txt   262829

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tcrg-20250430.xsd EX-101.SCH 3043
6 XBRL LABEL FILE tcrg-20250430_lab.xml EX-101.LAB 34235
7 XBRL PRESENTATION FILE tcrg-20250430_pre.xml EX-101.PRE 22376
19 EXTRACTED XBRL INSTANCE DOCUMENT tcrg8k050525_htm.xml XML 3772
Mailing Address 650 PONCE DE LEON AVE SUITE 300 #2334 ATLANTA GA 30308
Business Address 650 PONCE DE LEON AVE SUITE 300 #2334 ATLANTA GA 30308 404-254-2100
Cannaisseur Group Inc. (Filer) CIK: 0001879270 (see all company filings)

EIN.: 861907561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56664 | Film No.: 25913326
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)